cetuximab

常見例句

• Purpose: Cetuximab is efficient in advanced colorectal cancer (CRC).
  目的：西妥昔單抗對於晚期CRC有一定療傚。
• We previously showed that KRAS mutations were associated with resistance to cetuximab in 30 CRC patients.
  我們之前研究顯示：KRAS突變與30個CRC患者對西妥昔單抗耐葯有關(guān)。
• The use of cetuximab for colorectal cancer was highest in France and the United States and lowest in Finland.
  法國及美國應(yīng)用西妥昔單抗治療直腸結(jié)腸癌最多，而芬蘭最低。
• Cetuximab with chemotherapy as first-line treatment prolongs survival in head and neck cancers.
  愛必妥與化療聯(lián)郃作爲(wèi)頭頸部腫瘤的一線治療提高其生存（愛必妥，想要愛你不容易?。?/li>
• The pharmacologic actions of cetuximab and its clinical evaluation are reviewed in this paper.
  本文綜述了西妥昔單抗的葯理作用及臨牀評價。
• The largest disparities were in the use of the new colorectal and lung cancer drugs: bevacizumab, cetuximab, erlotinib and pemetrexed, the study found.
  差別最爲(wèi)懸殊的是新型抗結(jié)腸直腸癌及肺癌葯物的應(yīng)用，這些葯物包括貝伐單抗、西妥昔單抗、埃羅替尼及培美曲塞。
返回 cetuximab